ClinicalTrials.Veeva

Menu

Population Based Strategies for Standardized Surgical Care

University of Michigan logo

University of Michigan

Status

Begins enrollment in 3 months

Conditions

Hernia, Abdominal

Treatments

Behavioral: Replicating Effective Programs (REP)
Behavioral: REP with facilitation (REP-PLUS)

Study type

Interventional

Funder types

Other

Identifiers

NCT07106541
HUM00278185

Details and patient eligibility

About

Evidence-based guidelines to improve clinical care for abdominal wall hernia repair are common, but adherence is low. This proposal aims to evaluate a stakeholder informed Replicating Effective Programs (REP) using a randomized controlled Sequential Multiple Assignment Randomized Trial (SMART).

The study team will leverage the 68-hospital Michigan Surgical Quality Collaborative Core Optimization Hernia Registry (MSQCCOHR), a statewide collaborative focused on quality improvement in hernia care. The study team will explore optimal remediation strategies for underperforming sites as well as opportunities to de-intensify interventions for responder sites.

Enrollment

68 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All hospitals that participate in MSQC-COHR will be eligible to participate in the trial

Exclusion:

  • Institutes that are not in the MSQC-COHR

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

68 participants in 7 patient groups

Replicating Effective Programs (REP) - baseline program non-randomized
Experimental group
Description:
All sites participating will be given this REP. This will be evaluated over 12 months.
Treatment:
Behavioral: Replicating Effective Programs (REP)
REP with facilitation (REP-PLUS) - stage 1 randomized group
Experimental group
Description:
Non-responders to the initial baseline program of REP MSQC-COHR hospitals (defined as hospitals that do not demonstrate ≥85% adherence to guidelines) randomized to this arm. This randomized arm will be evaluated over 12 months.
Treatment:
Behavioral: REP with facilitation (REP-PLUS)
Replicating Effective Programs (REP) - stage 1 randomized group
Experimental group
Description:
Non-responder to the initial baseline program of MSQC-COHR hospitals (defined as hospitals that do not demonstrate ≥85% adherence to guidelines) randomized to this arm. This randomized arm will be evaluated over 12 months.
Treatment:
Behavioral: Replicating Effective Programs (REP)
Replicating Effective Programs (REP) (non-responders) - stage 2 randomized group
Experimental group
Description:
Twelve months after the stage 1, non-responder MSQC-COHR hospitals (defined as hospitals that do not demonstrate ≥85% adherence to guidelines) that were assigned to the REP arm will be re-randomized to this arm or REP-PLUS. This randomized arm will be evaluated over 12 months.
Treatment:
Behavioral: Replicating Effective Programs (REP)
REP with facilitation (REP-PLUS) (non-responders) - stage 2 randomized group
Experimental group
Description:
Twelve months after the stage 1, non-responder MSQC-COHR hospitals (defined as hospitals that do not demonstrate ≥85% adherence to guidelines) that were assigned to the REP arm will be re- randomized to this arm REP-PLUS or REP alone. This randomized arm will be evaluated over 12 months.
Treatment:
Behavioral: REP with facilitation (REP-PLUS)
REP-PLUS (responders) - stage 2 randomized group
Experimental group
Description:
This group will include the REP-PLUS responders from stage 1. The responding hospitals will that are re-randomized to this group will continue to receive REP-PLUS.
Treatment:
Behavioral: REP with facilitation (REP-PLUS)
Replicating Effective Programs (REP) (responders)- stage 2 randomized group
Experimental group
Description:
This group will include the REP-PLUS responders from stage 1. The responding hospitals will that are re-randomized to this group will receive REP alone.
Treatment:
Behavioral: Replicating Effective Programs (REP)

Trial contacts and locations

1

Loading...

Central trial contact

Alexander Hallway

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems